Travere Therapeutics Inc (TVTX)

Dec 21, 2024

Travere Therapeutics, Inc. (NASDAQ:TVTX) Holdings Decreased by State Street Corp - MarketBeat

Dec 21, 2024

Dec 20, 2024

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy - The Eastern Progress Online

Dec 20, 2024

Dec 20, 2024

XTX Topco Ltd Cuts Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Travere Therapeutics: Cautiously Bullish Based On Improving Revenue (NASDAQ:TVTX) - Seeking Alpha

Dec 19, 2024

Dec 18, 2024

Travere Therapeutics' SWOT analysis: stock poised for growth amid rare disease focus - Investing.com Canada

Dec 18, 2024

Dec 17, 2024

(TVTX) Investment Analysis - Stock Traders Daily

Dec 17, 2024

Dec 17, 2024

Y Intercept Hong Kong Ltd Lowers Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 17, 2024

Dec 15, 2024

Fmr LLC Acquires 31,772 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 15, 2024

Dec 12, 2024

Travere Therapeutics' SWOT analysis: rare disease stock poised for growth By Investing.com - Investing.com Canada

Dec 12, 2024

Dec 11, 2024

TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

Charles Schwab Investment Management Inc. Sells 1,184 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World

Dec 11, 2024

Dec 10, 2024

Two Sigma Advisers LP Increases Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 10, 2024

Dec 08, 2024

Travere Therapeutics, Inc. (NASDAQ:TVTX) Stock Holdings Lessened by Point72 Asia Singapore Pte. Ltd. - MarketBeat

Dec 08, 2024

Dec 05, 2024

Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat

Dec 05, 2024

Dec 05, 2024

Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 05, 2024

Dec 04, 2024

Parkman Healthcare Partners LLC Grows Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 04, 2024

Dec 03, 2024

HighVista Strategies LLC Decreases Stake in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 03, 2024

Dec 02, 2024

Bellevue Group AG Takes Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 02, 2024

Dec 01, 2024

Walleye Capital LLC Has $6.83 Million Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Dec 01, 2024

Nov 29, 2024

Healthcare of Ontario Pension Plan Trust Fund Purchases 228,300 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Nov 29, 2024

Nov 26, 2024

Travere Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Nov 26, 2024

Nov 25, 2024

Travere Therapeutics' SVP Calvin Sandra sells $221,257 in stock By Investing.com - Investing.com Nigeria

Nov 25, 2024

Nov 25, 2024

Travere Therapeutics' SVP Calvin Sandra sells $221,257 in stock - Investing.com India

Nov 25, 2024

Nov 25, 2024

Travere Therapeutics to Present at Evercore and Citi Healthcare Conferences in December | TVTX Stock News - StockTitan

Nov 25, 2024

Nov 23, 2024

Connor Clark & Lunn Investment Management Ltd. Increases Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Nov 23, 2024

Nov 21, 2024

Oppenheimer & Co. Inc. Buys Shares of 48,139 Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Nov 21, 2024

Nov 19, 2024

Kidney Disease Leader Travere Therapeutics Pulls Back To Key Level - Yahoo! Voices

Nov 19, 2024

Nov 18, 2024

Travere: Q3 Earnings Snapshot - AOL

Nov 18, 2024

Nov 18, 2024

Los Angeles Capital Management LLC Has $391,000 Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat

Nov 18, 2024

Nov 17, 2024

3 Under-the-Radar Healthcare Companies - MSN

Nov 17, 2024

Nov 15, 2024

When (TVTX) Moves Investors should Listen - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

Exploring Three High Growth Tech Stocks in the United States - Simply Wall St

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Travere The - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Woodline Partners LP Expands Stake in Travere Therapeutics Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Deep Track Capital, LP Reduces Stake in Travere Therapeutics Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $22.00 - MarketBeat

Nov 14, 2024

Nov 14, 2024

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 14, 2024

Nov 13, 2024

Travere Therapeutics Awards 24,400 RSUs to New Employees in Talent Acquisition Push | TVTX Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Eloxx Pharmac, Biogen, River 3 Renal Corp, Travere Therapeutics, Chinook Therapeutics - The Globe and Mail

Nov 13, 2024

Nov 13, 2024

Travere Therapeutics Completes $143.8 Million Public Offering - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares - The Manila Times

Nov 13, 2024